DIFFIGARD Trademark

Trademark Overview


On Friday, April 12, 2019, a trademark application was filed for DIFFIGARD with the United States Patent and Trademark Office. The USPTO has given the DIFFIGARD trademark a serial number of 88383946. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Tuesday, November 26, 2019. This trademark is owned by Pfizer Inc.. The DIFFIGARD trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use
diffigard

General Information


Serial Number88383946
Word MarkDIFFIGARD
Filing DateFriday, April 12, 2019
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateTuesday, November 26, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 30, 2019

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateTuesday, November 26, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Tuesday, November 26, 2019ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
Tuesday, November 26, 2019ABANDONMENT - AFTER PUBLICATION
Friday, November 22, 2019TEAS EXPRESS ABANDONMENT RECEIVED
Sunday, September 22, 2019CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Thursday, September 5, 2019TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, August 29, 2019EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, July 30, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 30, 2019PUBLISHED FOR OPPOSITION
Wednesday, July 10, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, June 22, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, June 22, 2019ASSIGNED TO EXAMINER
Wednesday, May 1, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, April 16, 2019NEW APPLICATION ENTERED IN TRAM